| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/28/2002 | WO2002016595A2 Kidney-specific protein |
| 02/28/2002 | WO2002016587A2 Microtubule-associated proteins and tubulins |
| 02/28/2002 | WO2002016585A2 Imidazoline receptor homologs |
| 02/28/2002 | WO2002016584A2 Process for the preparation of neutrophil inhibitory factor |
| 02/28/2002 | WO2002016440A2 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 02/28/2002 | WO2002016436A2 ANTIBODIES TO HUMAN IL-1$g(b) |
| 02/28/2002 | WO2002016433A2 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 02/28/2002 | WO2002016415A2 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | WO2002016401A2 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 02/28/2002 | WO2002016385A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
| 02/28/2002 | WO2002015939A2 Calycins |
| 02/28/2002 | WO2002015931A1 Immunologic method for the prevention of dental caries |
| 02/28/2002 | WO2002015927A1 High mannose proteins and methods of making high mannose proteins |
| 02/28/2002 | WO2002015846A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/28/2002 | WO2002015701A2 Bacillus thuringiensis crystal protein hybrids |
| 02/28/2002 | WO2002010372A8 Method of producing functional protein domains |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001081380A3 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 02/28/2002 | WO2001073029A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/28/2002 | WO2001070984A3 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 02/28/2002 | WO2001070255A3 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 02/28/2002 | WO2001068852A3 Apolipoprotein-a-i regulation of t-cell signalling |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001040266A3 Insect poison allergens with reduced ige reactivity and method for producing the same |
| 02/28/2002 | WO2001032702A3 Molecular structure of rhd negative locus |
| 02/28/2002 | WO2001023414B1 Immunologically significant herpes simplex virus antigens |
| 02/28/2002 | WO2000077037A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/28/2002 | WO2000050566A3 Genes encoding insect odorant receptors and uses thereof |
| 02/28/2002 | US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 02/28/2002 | US20020026042 Utilizing rabbit G alpha 16 polypeptides and polynucleotides in screening of antagonists or agonists of cells co-expressing a G-protein coupled receptor and rabbit G alpha 16; targets for drug discovery |
| 02/28/2002 | US20020026040 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases |
| 02/28/2002 | US20020026036 Constructing cassette vector by inserting cDNA coding for heavy chain constant region of human antibody into expression vector for animal cell use, establishing cloning site, digesting cdna coding for heavy chain, inserting into vector |
| 02/28/2002 | US20020025923 Antiinflammatory agents |
| 02/28/2002 | US20020025559 Nucleotide sequences for use in the diagnosis and treatment of hypertension, heart, and kidney defects |
| 02/28/2002 | US20020025558 Human MAD proteins and uses thereof |
| 02/28/2002 | US20020025551 Novel molecules of the t129-related protein family and uses thereof |
| 02/28/2002 | US20020025516 Nrde |
| 02/28/2002 | US20020025317 For therapy and prophylaxis of pathological condition associated with expression of Interelukin-12 and/or Interleukin-18, including excessive or inappropriate amounts of those cytokines |
| 02/28/2002 | US20020025305 Cell-cycle regulatory proteins, and uses related thereto |
| 02/28/2002 | DE10036469A1 Ultraspiracle (USP)-Protein von Heliothis virescens Ultraspiracle (USP) protein of Heliothis virescens |
| 02/28/2002 | CA2420477A1 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 02/28/2002 | CA2420330A1 Detecting polymers and polymer fragments |
| 02/28/2002 | CA2420257A1 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | CA2420198A1 Calycins |
| 02/28/2002 | CA2420101A1 Kidney-specific protein |
| 02/28/2002 | CA2420071A1 Process for the preparation of neutrophil inhibitory factor |
| 02/28/2002 | CA2420054A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
| 02/28/2002 | CA2419919A1 Novel imidazoline receptor homologs |
| 02/28/2002 | CA2419270A1 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 02/28/2002 | CA2419029A1 Bacillus thuringiensis crystal protein hybrids |
| 02/28/2002 | CA2417787A1 Lipid metabolism enzymes |
| 02/28/2002 | CA2417186A1 Microtubule-associated proteins and tubulins |
| 02/27/2002 | EP1182458A1 Method for detecting proteins under mutual interaction |
| 02/27/2002 | EP1182258A1 Mutants of the factor VII activating protease and methods for their detection |
| 02/27/2002 | EP1182212A2 Ultraspiracle USP-protetin of Heliothis virescens |
| 02/27/2002 | EP1181938A2 Rapamycin conjugates and antibodies |
| 02/27/2002 | EP1181549A1 Protein-protein interactions |
| 02/27/2002 | EP1181390A1 27 human secreted proteins |
| 02/27/2002 | EP1181385A2 Modulation of gene expression in gastrointestinal inflammation |
| 02/27/2002 | EP1181378A1 Fusion proteins comprising a fragment of a chaperon polypeptide |
| 02/27/2002 | EP1181369A1 Four-helical bundle protein zsig81 |
| 02/27/2002 | EP1181367A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
| 02/27/2002 | EP1181364A1 Lipid metabolism transcription factor |
| 02/27/2002 | EP1181363A1 Recombinant human mannan-binding lectin |
| 02/27/2002 | EP1181356A2 Enzymatic reductions with dihydrogen via metal catalyzed cofactor regeneration |
| 02/27/2002 | EP1181351A1 Method of purifying heterologous proteins |
| 02/27/2002 | EP1181319A1 Dr4 antibodies and uses thereof |
| 02/27/2002 | EP1181318A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 02/27/2002 | EP1181317A1 An integrin heterodimer and an alpha subunit thereof |
| 02/27/2002 | EP1181316A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
| 02/27/2002 | EP1181315A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| 02/27/2002 | EP1181306A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/27/2002 | EP1181303A1 50 human secreted proteins |
| 02/27/2002 | EP1181056A1 Lim mineralization protein splice variants |
| 02/27/2002 | EP1181038A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 02/27/2002 | EP1181037A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 02/27/2002 | EP1180999A2 Recombinant vaccine against botulinum neurotoxin |
| 02/27/2002 | EP0836380B1 Fgf9 as a specific ligand for fgfr3 |
| 02/27/2002 | EP0536330B1 Glyphosate tolerant plants |
| 02/27/2002 | CN1337834A Power amplifier share in wireless communication system with transmitting diversity |
| 02/27/2002 | CN1337405A Sodium-ion drived chlorine-ion/exchange protein bicarbonate |
| 02/27/2002 | CN1079837C Method for preparing cyclocyto polypeptide A from branched layer wall bacterium |
| 02/27/2002 | CN1079832C Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell |
| 02/27/2002 | CN1079831C Gene encoding carboxypeptidase of aspergillus niger |
| 02/26/2002 | US6350866 A nucleic acid encoding a protein; for developing and screening drugs that bind and inhibit the protein; therapy for respiratory diseases |
| 02/26/2002 | US6350861 A site directed mutagenic immunoglobulin having a mutations in the variable region that changes the glycosylation pattern; diagnosis and therapy for autoimmune diseases, cancers and viral diseases |
| 02/26/2002 | US6350858 A polypeptide involved in controlling phosphate retention; diagnosis and therapy for chronic kidney failure, end stage kidney disease, uremic bone disease, and cancer |
| 02/26/2002 | US6350857 Fifty-four homologue (ffh) from streptococcus pneumoniae |
| 02/26/2002 | US6350856 Cytokine suppressive anti-inflammatory drug binding protein |
| 02/26/2002 | US6350855 Human interleukin-11 receptor |
| 02/26/2002 | US6350854 Isolated 55 to 72 kDa protein which binds to prion proteins |
| 02/26/2002 | US6350612 Cloned and sequenced eco ri fragment of bordetella pertussis chromosomal dna with 4696 base pairs containing genes which code for five subunits of pertussis toxin or fragments thereof containing at least one gene which codes for subunit of toxin |
| 02/26/2002 | US6350603 Phosphodiesterase 10 |
| 02/26/2002 | US6350598 MurD |
| 02/26/2002 | US6350593 Receptors for fibroblast growth factors |
| 02/26/2002 | US6350592 Aortic-specific enhancer sequence and uses thereof |
| 02/26/2002 | US6350581 Tumor-associated antigen |
| 02/26/2002 | US6350575 Helper viruses for the preparation of recombinant viral vectors |
| 02/26/2002 | US6350452 Composition comprising antibody immunoreactive with neoepitope produced in cell undergoing apoptosis, said neoepitope comprising amino terminus produced by cleavage of protein at cleavage site cleaved by protease during apoptosis |